Market Samachar
CNBC
·
GLOBAL
·
Novo and Lilly are competing to win the GLP-1 pill market as they prepare for Medicare coverage - CNBC
As reported by CNBC
Novo Nordisk and Eli Lilly bring their longtime rivalry to GLP-1 pills and prepare to make their pitch to seniors with Medicare.
▸ MARKET SAMACHAR VIEW
NEUTRAL
Read full article on CNBC ↗
Market Samachar is a news aggregator. This article was originally published by
CNBC. Tap the button above to read the full story on their site.
🔥 Hot Now
Top stories across markets in the last hour
More from Market Samachar